AVENUE THERAPEUTICS, INC. cotiza a 0.40 USD y tiene una capitalización bursátil de $1M. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
Avenue Therapeutics, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of therapies for the treatment of neurologic diseases. The company product candidates include ATX-04, a small molecule therapy for the treatment of Pompe disease; and intravenous tramadol, a schedule IV opioi…
| Periodo | 2024-11 | 2024-08 | 2024-05 | 2024-03 |
|---|---|---|---|---|
| Real | $-1.92 | $-2.41 | $-15.40 | $42.00 |
| Estimado | $-0.94 | $-1.05 | $-9.00 | $-7.50 |
| Sorpresa | -104.3% | -129.5% | -71.1% | +660.0% |
| Métrica | ATXI | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | — | 57.0% | — |
| Operating Margin | -219.6% | -38.6% | -181.0% |
| Net Margin | -207.2% | -33.6% | -173.6% |
| FCF Margin | — | -13.9% | — |
| ROE | -158.8% | -40.4% | -118.4% |
| ROA | -99.3% | -32.0% | -67.2% |
| Current Ratio | — | 2.84 | — |
| Debt / Equity | — | 0.28 | — |